Navitoclax-impurities | Pharmaffiliates

navitoclax and its Impurities

Navitoclax is an orally bioavailable small molecule inhibitor of Bcl-2 family proteins. It has been used in trials studying the treatment and basic science of Solid Tumors, Non-Hodgkin's Lymphoma, EGFR Activating Mutation, Chronic Lymphoid Leukemia, and Hematological Malignancies, among others. Reference standards of Navitoclax API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 1 results for navitoclax Impurities
PA 14 82000

Navitoclax - API


  • Catalogue No.:PA 14 82000

  • CAS :


  • Molecular Formula : C47H55ClF3N5O6S3

  • Molecular Weight : 974.61